key: cord-0827703-cp300n0r
authors: Nachimuthu, Sukanya; Viswanathan, Vijay
title: Trend in COVID-19 vaccination among people with diabetes: A short study from India
date: 2021-06-29
journal: Diabetes Metab Syndr
DOI: 10.1016/j.dsx.2021.102190
sha: 53ab21abd0197ef4f47e599aa4eb927c740f04f7
doc_id: 827703
cord_uid: cp300n0r

nan

With the widely known measures to prevent COVID-19, one more is added to the list. That is, the COVID-19 vaccine (two vaccines-Covishield: AstraZeneca-Serum Institute of India) and Covaxin(Bharat Biotech Limited) 1 authorized by the Drugs Controller General of India for emergency use. As people with co-morbidities above 45 years were announced eligible for vaccination in India, we conducted a survey among the out-patients to know the number of people vaccinated and the reasons for not taking it. (Figure 1 ).

Vaccine hesitations developed from the day of the announcement of the development of vaccines against COVID-19 worldwide. It includes the efficacy of the vaccines, safety, duration of protection, health literacy, misinformation, lack of trust, need for additional information and cost of the vaccination 2,3,4,5 studies across countries. Physicians play a crucial role in this education and spreading the awareness as the people mostly rely on them for decision making and to break the hesitance. 

MoHFW-Frequently asked questions

Acceptance of a Covid-19 vaccine is associated with ability to detect fake news and health literacy

COVID-19 Vaccination Acceptance and Its Associated Factors Among a Middle Eastern Population. Front Public Health

Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults

COVID-19 Communication Stratergy. MoHFW. Dated: 17 th